 Albumin Market Insights, Competitive Landscape, and Market Forecast - 2033
The global albumin market continues to demonstrate consistent growth, driven by its expanding role across medical, pharmaceutical, and research domains. Albumin, a vital protein derived from plasma... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global albumin market continues to demonstrate consistent growth, driven by its expanding role across medical, pharmaceutical, and research domains. Albumin, a vital protein derived from plasma or produced through recombinant technologies, is widely utilized in therapies for critical conditions, drug formulation, and laboratory applications. As healthcare systems worldwide evolve and biotechnology advances, the demand for albumin is steadily increasing. The growing importance of safe and effective treatment solutions, combined with the rising use of biologics, is reinforcing the market’s long-term potential.Market Insights The albumin market is expected to be valued at US$ 7.7 billion in 2026 and is projected to reach US$ 11.2 billion by 2033, expanding at a CAGR of 5.50% during the forecast period. This upward trend reflects a strong demand for albumin in therapeutic procedures and an increasing focus on high-quality biological products. Improvements in plasma fractionation processes and advancements in recombinant albumin manufacturing are also contributing to the market’s steady expansion. The industry is further supported by a growing emphasis on patient safety and regulatory compliance. Market Drivers A major factor driving the albumin market is the increasing incidence of chronic and acute medical conditions such as liver cirrhosis, burns, trauma, and infections. Albumin is widely used in volume resuscitation and critical care settings, making it an essential component in modern healthcare. The rising number of surgical procedures and hospital admissions is also boosting demand. Another important driver is the growing application of albumin in drug delivery systems. Its natural binding properties enable enhanced drug stability and targeted delivery, which is particularly beneficial in oncology and advanced therapeutics. Additionally, the rapid expansion of the biotechnology sector and increased investment in life sciences research are accelerating the use of recombinant albumin. This form offers improved safety, scalability, and consistency, reducing reliance on plasma-derived sources and supporting sustainable growth. Business Opportunity The albumin market presents significant opportunities for innovation and expansion, particularly in the field of recombinant technology. Manufacturers are increasingly investing in research to develop high-purity albumin products that meet stringent regulatory standards. This shift is expected to reduce dependency on human plasma and open new commercial avenues. Emerging economies offer strong growth prospects due to rising healthcare investments, expanding pharmaceutical industries, and increasing awareness of advanced treatment options. The demand for albumin in diagnostics and research is also growing, driven by the expansion of clinical trials and laboratory studies. Furthermore, strategic collaborations, mergers, and partnerships among key players are enhancing product portfolios and global reach. These initiatives are enabling companies to strengthen their market presence and capitalize on evolving industry trends. Region Analysis North America remains a dominant region in the albumin market, supported by advanced healthcare infrastructure, high healthcare spending, and strong research capabilities. The presence of major pharmaceutical and biotechnology companies further strengthens the region’s position. Europe also holds a significant share, driven by increasing demand for plasma-derived therapies and supportive regulatory frameworks. Continuous investments in research and innovation are contributing to market growth across the region. Asia Pacific is expected to witness the fastest growth during the forecast period. Factors such as a large patient population, improving healthcare systems, and rising awareness of advanced therapies are driving demand. Countries like China and India are playing a crucial role in regional expansion. Latin America and the Middle East & Africa are gradually emerging as promising markets, supported by improving healthcare access and increasing adoption of modern treatment solutions. These regions are expected to offer new opportunities for market players in the coming years. Key Players • CSL Behring • Grifols, S.A. • Takeda Pharmaceutical Company Limited • Octapharma AG • Merck KGaA • Baxter International Inc. • Kedrion Biopharma • Thermo Fisher Scientific Inc. • Albumedix (Sartorius AG) • Albumin Bioscience • InVitria (Ventria Bioscience) • China Biologic Products Inc. • Hualan Biological Engineering Inc. • Shanghai RAAS Blood Products Co., Ltd. • HiMedia Laboratories Pvt. Ltd. Segmentation By Product • Human Serum Albumin • Recombinant Albumin • Bovine Serum Albumin By Application • Therapeutics • Diagnostics • Research By End-user • Hospital & Clinics • Pharmaceutical & Biotechnology Industry • Research Institutes By Geography • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Albumin Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Albumin Market Outlook, 2020 - 2033 3.1. Global Albumin Market Outlook, by Product, Value (US$ Bn), 2020-2033 3.1.1. Human Serum Albumin 3.1.2. Recombinant Albumin 3.1.3. Bovine Serum Albumin 3.2. Global Albumin Market Outlook, by Application, Value (US$ Bn), 2020-2033 3.2.1. Therapeutics 3.2.2. Diagnostics 3.2.3. Research 3.3. Global Albumin Market Outlook, by End-user, Value (US$ Bn), 2020-2033 3.3.1. Hospital & Clinics 3.3.2. Pharmaceutical & Biotechnology Industry 3.3.3. Research Institutes 3.4. Global Albumin Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Latin America 3.4.5. Middle East & Africa 4. North America Albumin Market Outlook, 2020 - 2033 4.1. North America Albumin Market Outlook, by Product, Value (US$ Bn), 2020-2033 4.1.1. Human Serum Albumin 4.1.2. Recombinant Albumin 4.1.3. Bovine Serum Albumin 4.2. North America Albumin Market Outlook, by Application, Value (US$ Bn), 2020-2033 4.2.1. Therapeutics 4.2.2. Diagnostics 4.2.3. Research 4.3. North America Albumin Market Outlook, by End-user, Value (US$ Bn), 2020-2033 4.3.1. Hospital & Clinics 4.3.2. Pharmaceutical & Biotechnology Industry 4.3.3. Research Institutes 4.4. North America Albumin Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.4.1. U.S. Albumin Market Outlook, by Product, 2020-2033 4.4.2. U.S. Albumin Market Outlook, by Application, 2020-2033 4.4.3. U.S. Albumin Market Outlook, by End-user, 2020-2033 4.4.4. Canada Albumin Market Outlook, by Product, 2020-2033 4.4.5. Canada Albumin Market Outlook, by Application, 2020-2033 4.4.6. Canada Albumin Market Outlook, by End-user, 2020-2033 4.5. BPS Analysis/Market Attractiveness Analysis 5. Europe Albumin Market Outlook, 2020 - 2033 5.1. Europe Albumin Market Outlook, by Product, Value (US$ Bn), 2020-2033 5.1.1. Human Serum Albumin 5.1.2. Recombinant Albumin 5.1.3. Bovine Serum Albumin 5.2. Europe Albumin Market Outlook, by Application, Value (US$ Bn), 2020-2033 5.2.1. Therapeutics 5.2.2. Diagnostics 5.2.3. Research 5.3. Europe Albumin Market Outlook, by End-user, Value (US$ Bn), 2020-2033 5.3.1. Hospital & Clinics 5.3.2. Pharmaceutical & Biotechnology Industry 5.3.3. Research Institutes 5.4. Europe Albumin Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.4.1. Germany Albumin Market Outlook, by Product, 2020-2033 5.4.2. Germany Albumin Market Outlook, by Application, 2020-2033 5.4.3. Germany Albumin Market Outlook, by End-user, 2020-2033 5.4.4. Italy Albumin Market Outlook, by Product, 2020-2033 5.4.5. Italy Albumin Market Outlook, by Application, 2020-2033 5.4.6. Italy Albumin Market Outlook, by End-user, 2020-2033 5.4.7. France Albumin Market Outlook, by Product, 2020-2033 5.4.8. France Albumin Market Outlook, by Application, 2020-2033 5.4.9. France Albumin Market Outlook, by End-user, 2020-2033 5.4.10. U.K. Albumin Market Outlook, by Product, 2020-2033 5.4.11. U.K. Albumin Market Outlook, by Application, 2020-2033 5.4.12. U.K. Albumin Market Outlook, by End-user, 2020-2033 5.4.13. Spain Albumin Market Outlook, by Product, 2020-2033 5.4.14. Spain Albumin Market Outlook, by Application, 2020-2033 5.4.15. Spain Albumin Market Outlook, by End-user, 2020-2033 5.4.16. Russia Albumin Market Outlook, by Product, 2020-2033 5.4.17. Russia Albumin Market Outlook, by Application, 2020-2033 5.4.18. Russia Albumin Market Outlook, by End-user, 2020-2033 5.4.19. Rest of Europe Albumin Market Outlook, by Product, 2020-2033 5.4.20. Rest of Europe Albumin Market Outlook, by Application, 2020-2033 5.4.21. Rest of Europe Albumin Market Outlook, by End-user, 2020-2033 5.5. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Albumin Market Outlook, 2020 - 2033 6.1. Asia Pacific Albumin Market Outlook, by Product, Value (US$ Bn), 2020-2033 6.1.1. Human Serum Albumin 6.1.2. Recombinant Albumin 6.1.3. Bovine Serum Albumin 6.2. Asia Pacific Albumin Market Outlook, by Application, Value (US$ Bn), 2020-2033 6.2.1. Therapeutics 6.2.2. Diagnostics 6.2.3. Research 6.3. Asia Pacific Albumin Market Outlook, by End-user, Value (US$ Bn), 2020-2033 6.3.1. Hospital & Clinics 6.3.2. Pharmaceutical & Biotechnology Industry 6.3.3. Research Institutes 6.4. Asia Pacific Albumin Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.4.1. China Albumin Market Outlook, by Product, 2020-2033 6.4.2. China Albumin Market Outlook, by Application, 2020-2033 6.4.3. China Albumin Market Outlook, by End-user, 2020-2033 6.4.4. Japan Albumin Market Outlook, by Product, 2020-2033 6.4.5. Japan Albumin Market Outlook, by Application, 2020-2033 6.4.6. Japan Albumin Market Outlook, by End-user, 2020-2033 6.4.7. South Korea Albumin Market Outlook, by Product, 2020-2033 6.4.8. South Korea Albumin Market Outlook, by Application, 2020-2033 6.4.9. South Korea Albumin Market Outlook, by End-user, 2020-2033 6.4.10. India Albumin Market Outlook, by Product, 2020-2033 6.4.11. India Albumin Market Outlook, by Application, 2020-2033 6.4.12. India Albumin Market Outlook, by End-user, 2020-2033 6.4.13. Southeast Asia Albumin Market Outlook, by Product, 2020-2033 6.4.14. Southeast Asia Albumin Market Outlook, by Application, 2020-2033 6.4.15. Southeast Asia Albumin Market Outlook, by End-user, 2020-2033 6.4.16. Rest of SAO Albumin Market Outlook, by Product, 2020-2033 6.4.17. Rest of SAO Albumin Market Outlook, by Application, 2020-2033 6.4.18. Rest of SAO Albumin Market Outlook, by End-user, 2020-2033 6.5. BPS Analysis/Market Attractiveness Analysis 7. Latin America Albumin Market Outlook, 2020 - 2033 7.1. Latin America Albumin Market Outlook, by Product, Value (US$ Bn), 2020-2033 7.1.1. Human Serum Albumin 7.1.2. Recombinant Albumin 7.1.3. Bovine Serum Albumin 7.2. Latin America Albumin Market Outlook, by Application, Value (US$ Bn), 2020-2033 7.2.1. Therapeutics 7.2.2. Diagnostics 7.2.3. Research 7.3. Latin America Albumin Market Outlook, by End-user, Value (US$ Bn), 2020-2033 7.3.1. Hospital & Clinics 7.3.2. Pharmaceutical & Biotechnology Industry 7.3.3. Research Institutes 7.4. Latin America Albumin Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.4.1. Brazil Albumin Market Outlook, by Product, 2020-2033 7.4.2. Brazil Albumin Market Outlook, by Application, 2020-2033 7.4.3. Brazil Albumin Market Outlook, by End-user, 2020-2033 7.4.4. Mexico Albumin Market Outlook, by Product, 2020-2033 7.4.5. Mexico Albumin Market Outlook, by Application, 2020-2033 7.4.6. Mexico Albumin Market Outlook, by End-user, 2020-2033 7.4.7. Argentina Albumin Market Outlook, by Product, 2020-2033 7.4.8. Argentina Albumin Market Outlook, by Application, 2020-2033 7.4.9. Argentina Albumin Market Outlook, by End-user, 2020-2033 7.4.10. Rest of LATAM Albumin Market Outlook, by Product, 2020-2033 7.4.11. Rest of LATAM Albumin Market Outlook, by Application, 2020-2033 7.4.12. Rest of LATAM Albumin Market Outlook, by End-user, 2020-2033 7.5. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Albumin Market Outlook, 2020 - 2033 8.1. Middle East & Africa Albumin Market Outlook, by Product, Value (US$ Bn), 2020-2033 8.1.1. Human Serum Albumin 8.1.2. Recombinant Albumin 8.1.3. Bovine Serum Albumin 8.2. Middle East & Africa Albumin Market Outlook, by Application, Value (US$ Bn), 2020-2033 8.2.1. Therapeutics 8.2.2. Diagnostics 8.2.3. Research 8.3. Middle East & Africa Albumin Market Outlook, by End-user, Value (US$ Bn), 2020-2033 8.3.1. Hospital & Clinics 8.3.2. Pharmaceutical & Biotechnology Industry 8.3.3. Research Institutes 8.4. Middle East & Africa Albumin Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.4.1. GCC Albumin Market Outlook, by Product, 2020-2033 8.4.2. GCC Albumin Market Outlook, by Application, 2020-2033 8.4.3. GCC Albumin Market Outlook, by End-user, 2020-2033 8.4.4. South Africa Albumin Market Outlook, by Product, 2020-2033 8.4.5. South Africa Albumin Market Outlook, by Application, 2020-2033 8.4.6. South Africa Albumin Market Outlook, by End-user, 2020-2033 8.4.7. Egypt Albumin Market Outlook, by Product, 2020-2033 8.4.8. Egypt Albumin Market Outlook, by Application, 2020-2033 8.4.9. Egypt Albumin Market Outlook, by End-user, 2020-2033 8.4.10. Nigeria Albumin Market Outlook, by Product, 2020-2033 8.4.11. Nigeria Albumin Market Outlook, by Application, 2020-2033 8.4.12. Nigeria Albumin Market Outlook, by End-user, 2020-2033 8.4.13. Rest of Middle East Albumin Market Outlook, by Product, 2020-2033 8.4.14. Rest of Middle East Albumin Market Outlook, by Application, 2020-2033 8.4.15. Rest of Middle East Albumin Market Outlook, by End-user, 2020-2033 8.5. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. CSL Behring 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Grifols, S.A. 9.4.3. Takeda Pharmaceutical Company Limited 9.4.4. Octapharma AG 9.4.5. Merck KGaA 9.4.6. Baxter International Inc. 9.4.7. Kedrion Biopharma 9.4.8. Thermo Fisher Scientific Inc. 9.4.9. Albumedix (Sartorius AG) 9.4.10. Albumin Bioscience 9.4.11. InVitria (Ventria Bioscience) 9.4.12. China Biologic Products Inc. 9.4.13. Hualan Biological Engineering Inc. 9.4.14. Shanghai RAAS Blood Products Co., Ltd. 9.4.15. HiMedia Laboratories Pvt. Ltd. 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（環境・エネルギー）の最新刊レポート
Fairfield Market Research社の エネルギー・天然資源分野 での最新刊レポート
本レポートと同じKEY WORD（albumin）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
